Rodrigo-Calvo Maria Teresa, Saez de Gordoa Karmele, Lopez-Prades Sandra, Archilla Ivan, Diaz Alba, Berrios Mario, Camps Jordi, Musulen Eva, Cuatrecasas Miriam
Pathology Department, Centre of Biomedical Diagnosis (CDB), Hospital Clinic, 08036 Barcelona, Spain.
Molecular Pathology of Inflammatory Conditions and Solid Tumours Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Cancers (Basel). 2023 Jan 30;15(3):842. doi: 10.3390/cancers15030842.
Lymph node (LN) metastasis is an important prognostic factor in colorectal cancer (CRC). We aimed to demonstrate the presence of lymphatic vessels (LV) in the mucosa of in-situ (pTis) CRC, and of detectable tumour burden in regional LNs. This is an observational retrospective study of 39 surgically resected in situ CRCs. The number of LVs was evaluated in both pTis and normal mucosa using D2-40 immunostains. All LNs were assessed with both H&E and the One Step Nucleic Acid Amplification (OSNA) assay, and the results were correlated with clinicopathological features. D2-40 immunohistochemisty revealed LVs in the lamina propria of all pTis CRC (100%), being absent in normal mucosa. A median of 16 LNs were freshly dissected per patient, and all cases were pN0 with H&E. Molecular LN analysis with OSNA revealed the presence of low amounts of tumour burden in 11/39 (28%) cases (range 400 to 4270 CK19 mRNA copies/µL), which had no clinical consequences. This study demonstrates the presence of LVs in the lamina propria in 100% of pTis CRC, as well as the presence of low amounts of tumour burden in regional LNs, only detected by molecular methods. Given the prognostic value of LN tumour burden, its molecular quantification may help a patient's clinical management.
淋巴结(LN)转移是结直肠癌(CRC)的一个重要预后因素。我们旨在证明原位(pTis)CRC黏膜中淋巴管(LV)的存在,以及区域淋巴结中可检测到的肿瘤负荷。这是一项对39例手术切除的原位CRC进行的观察性回顾性研究。使用D2-40免疫染色评估pTis和正常黏膜中的LV数量。所有淋巴结均用苏木精和伊红(H&E)染色以及一步核酸扩增(OSNA)检测进行评估,结果与临床病理特征相关。D2-40免疫组化显示,所有pTis CRC的固有层中均有LV(100%),而正常黏膜中不存在。每位患者新鲜解剖的淋巴结中位数为16个,所有病例H&E染色均为pN0。OSNA对淋巴结进行分子分析显示,11/39(28%)的病例存在少量肿瘤负荷(范围为400至4270个细胞角蛋白19(CK19)mRNA拷贝/微升),但无临床后果。本研究证明,100%的pTis CRC固有层中存在LV,以及区域淋巴结中存在少量肿瘤负荷,且仅通过分子方法才能检测到。鉴于淋巴结肿瘤负荷的预后价值,其分子定量可能有助于患者的临床管理。